Sofwave Medical reported Q2 2026 revenue of $30 million, a 43% year-over-year increase, reflecting robust adoption of its ultrasound-based microneedling platform. The company has been gaining traction in the competitive energy-device space against RF and laser competitors.
Devices & Tech
Sofwave Q2 Revenue Jumps 43% YoY to $30M
Ultrasound microneedling device maker posts strong growth, signaling sustained demand for energy-based platforms.
